Development and evaluation of regioselective bilayer floating tablets of Atenolol and Lovastatin for biphasic release profile

Iranian Journal of Pharmaceutical Research

Volumn 8, Issue 1, 2009, Pages 15-25

  Kulkarni, Ajit ^a   Bhatia, Manish ^a  

^a BHARATI VIDYAPEETH COLLEGE OF PHARMACY   (India)

Author keywords

Atenolol; Bilayer tablets; Floating; Lovastatin; Regioselective

Indexed keywords

ATENOLOL; BICARBONATE; CALCIUM PHOSPHATE DIBASIC; LACTOSE; MAGNESIUM STEARATE; MEVINOLIN; POLYMER; STARCH GLYCOLATE SODIUM; XANTHAN;

ADULT; ARTICLE; BILAYER FLOATING TABLET; CONTROLLED RELEASE FORMULATION; DRUG DEGRADATION; DRUG RELEASE; DRUG STABILITY; HUMAN; HUMAN EXPERIMENT; IMMEDIATE RELEASE FORMULATION; IN VIVO STUDY; NORMAL HUMAN; RADIOGRAPHY; SUSTAINED RELEASE FORMULATION; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET FORMULATION; TABLET HARDNESS; THERMOSTABILITY;

EID: 67649097330     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Rahman Z, Ali M and Khar RK. Design and evaluation of bilayer floating tablets of captopril. Acta Pharm. (2006) 56: 49-57
2. Wei Z, Yu Z and Bi D. Design and evaluation of a two layer floating tablets for gastric retention using cisapride as a model drug. Drug Dev. Ind. Pharm. (2001) 27: 469-474
3. Patel VF and Patel NM. Intragastric floating drug delivery system of cefuroxime axetil: in vitro evaluation. AAPS Pharm. Sci. Tech. (2006) 7: E1-E7
4. Nur AO and Zhang JS. Captopril floating and/or bioadhesive tablets: design and release kinetics. Drug Dev. Ind. Pharm. (2000) 26: 965-969
5. Patel VF and Patel NM. Statistical evaluation of influence of xanthan gum and guar gum blends on dipyridamole release from floating matrix tablets. Drug Dev. Ind. Pharm. (2007) 33: 327-334
6. Li S, Lin S, Daggy BP, Mirchandani HL and Chien YW. Effect of HPMC and carbopol on the release and floating properties of gastric floating drug delivery system using factorial design. Int. J. Pharm. (2003) 253: 13-22
7. Rouge N, Alleman E, Gex-Fabry M, Balant L, Cole ET, Buri P and Doelker E. Comparative pharmacokinetic study of a floating multiple unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. Pharm. Acta Hel. (1998) 73: 81-87
8. Sungthongjeen S, Paeratakul O, Limmatvapirat S and Puttipipatkhachorn S. Preparation and in vivo evaluation of a multiple-unit floating drug delivery system based on gas formation technique. Int. J. Pharm. (2006) 324: 136-143
9. Patel DM, Patel NM, Patel VF and Bhatt DA. Floating granules of ranitidine hydrochloride-gelucire 43/01: formulation optimization using factorial design. AAPS Pharm. Sci. Tech. (2007) 8: E1-E7
10. Rocca J, Omidian H and Shah K. Progress in gastroretentive drug delivery systems. Pharmatech. (1998) 152-156
11. Melander A, Stenberg P, Liedholm H, Schersten B and Wahlin-Boll E. Food induced reduction in bioavailability of atenolol. Eur. J. Clin. Pharm. (1979) 16: 327-330
12. Amidon GL, Lennernas H, Shah VP and Crison JR. A theoretical basis for a biopharmacutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. (1995) 12: 413-420
13. Dollery C. Therapeutic Drugs. Churchill Livingstone, Edinburgh (1999) L105-L109
14. Tripathi KD. Essentials of Medical Pharmacology. Jaypee Brothers Medical Publications, New Delhi (2003) 145
15. Dollery C. Therapeutic Drugs. Churchill Livingstone, Edinburgh (1999) D139-D143
16. Pool JL, Shear CL, Downton M, Schnaper H, Stinnett S, Dujovne C, Bradford RH and Chremos AN. Lovastatin and coadministered antihypertensive/cardiovascular agents. Hypertension (1992) 19: 242-248
17. Rubin R, Silbiger S, Sablay L and Neugarten J. Combined antihypertensive and lipid-lowering therapy in experimental glomerulonephritis. Hyper. Aha. J. (2007) 92-95
18. Faggiotto A and Paoletti R. Statins and blockers of the renin-angiotensin system. Hypertension (1999) 34: 987-996
19. Stability Testing Guidelines. Stability Testing of New Drug Substances and Products. (2003)
20. United States Pharmacopoeia. 23rd ed. US Pharmacopoeial Convention, Rockville (1993) 951
21. Dyade GK and Sharma AK. Simultaneous spectrophotometric estimation of spironolactone and hydroflumethiazide in tablet formulations. Ind. Drugs (2001) 38: 75-78
22. Khan MR and Jain D. Simultaneous spectrophotometric determination of atorvastatin calcium and amlodipine besylate in tablets. Ind. J. Pharm. Sci. (2006) 68: 546-548
23. Sachan A and Trivedi P. Simultaneous spectrophotometric estimation of tripprolidine hydrochloride and phenylpropanalamine hydrochloride. East-Pharm. (1999) XLII: 107-110
24. Siepmann J and Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug. Deli. Rev. (2001) 48: 139-157
25. Costa P and Lobo JMS. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. (2001) 13: 123-133
26. Banker GS and Anderson NR. Tablets. In: Lachman L, Lieberman H and Kanig JL. (eds.) (eds.) The Theory and Practice of Industrial Pharmacy. Varghese Publishing House, Bombay (1998) 298-301
27. Shahrzad M and Reza F. Release characterization of dimenhydrinate from an eroding and swelling index: selection of appropriate dissolution apparatus. Int. J. Pharm. (2005) 293: 35-42
28. Nagel A and Blazevic N. Atenolol. In: Brittain HG. (ed.) Analytical Profiles of Drug Substances. Academic Press Inc., California (2005) 1-25
29. Brenner GS, Ellison DK and Kaufman MJ. Lovastatin. Lovastatin. In: Brittain HG (ed.) Analytical Profiles of Drug Substances. Academic Press Inc., California (2005) 277-305
30. Talukdar MM and Kinget R. Swelling and drug release behaviour of xanthan gum matrix tablets. Int. J. Pharm. (1995) 120: 63-72
31. Talukdar MM and Kinget R. Comparative study on xanthan gum and hydroxypropylmethyl cellulose for controlled-release drug delivery. II. Drug diffusion in hydrated matrices. Int. J. Pharm. (1997) 151: 99-107
32. Conti S, Maggi L, Segale L, Machiste EO, Conte U, Grenier P and Vergnault G. Matrices containing NaCMC and HPMC. 1. Dissolution Performance and characteristics. Int. J. Pharm. (2007) 333: 136-142
33. Mehrgan H and Mortazavi SA. The release behavior and kinetic evaluation of atenolol from various hydrophilic and plastic based matrices. Iranian J. Pharm. Res. (2005) 3: 137-146
34. Tiwari SB, Murthy TK, Pai MR, Mehta PR and Chowdary PB. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS Pharm. Sci. Tech. (2003) 4: 31
35. Reza MS, Quadir MA and Haider SS. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery. J. Pharm. Pharmaceut. Sci. (2003) 6: 282-291